A Bench To Bedside Approach To Improving Treatment Of Blinding Retinal Diseases
Funder
National Health and Medical Research Council
Funding Amount
$452,051.00
Summary
I am a retinal specialist and clinician scientist directing a group dedicated to identifying improved treatments for blinding macular disease. My clinical research unit conducts randomised clinical trials and pioneered the use of intraocular steroid therapy. My Laboratory research group is interested in stem cell therapy, proteomic analysis of macular disease and the role of Muller cell dysfunction in retinal vascular disease.
Assessing The Role Of The N-terminus Of The Prion Protein, Emphasising Constitutive Cleavage, In Normal Function And Pathogenesis, As Well As Defining The Relationship Between Intensity Of Surveillance And Sporadic CJD Incidence.
Funder
National Health and Medical Research Council
Funding Amount
$387,469.00
Summary
As a neurologist undertaking research into prion diseases over an extended period, I have been able to lead and participate in many projects that have made significant contributions, such as validation of new diagnostic tests for Creutzfeldt-Jakob disease (CJD), assessment of potential therapeutics, provide insights into the normal function of the prion protein and the underlying pathways causing cellular damage and determine the real significance of apparent clusters of sporadic CJD.